FilingReader Intelligence
Bharat Parenterals posts 25% consolidated revenue jump
July 28, 2025 at 12:40 PM UTC•By FilingReader AI
Bharat Parenterals Limited reported consolidated revenue from operations jumped 25.4% to INR 116.00 crore in Q1 FY26, compared to INR 92.51 crore in Q1 FY25.
Consolidated EBITDA saw a substantial increase of 206.9% to INR 13.78 crore, resulting in an EBITDA margin of 11.9%.
Standalone revenue from operations increased 2.51% to INR 94.37 crore. The company projects 12-14% revenue growth for FY26 in its standalone business.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:BPLPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when Bharat Parenterals publishes news
Free account required • Unsubscribe anytime